Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$13.54 USD
-0.12 (-0.88%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $13.42 -0.12 (-0.89%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CCRN 13.54 -0.12(-0.88%)
Will CCRN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CCRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CCRN
New Strong Sell Stocks for August 20th
Cross Country Healthcare (CCRN) Reports Q2 Loss, Misses Revenue Estimates
CCRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Kforce (KFRC) Lags Q2 Earnings Estimates
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
Cross Country Healthcare (CCRN) Q1 Earnings Top Estimates
Other News for CCRN
CCRN falls 0.88% on September 19, leaving the technical picture intact
Technical picture remains unchanged for CCRN after it rises 4.12% on September 18
The technical outlook for CCRN is unchanged after it rises 1.86% on September 17
Cross Country Healthcare (CCRN) Shares Rise Amid FTC Speculation
Cross Country Healthcare gains on speculation it wasn't subject of FTC meeting